State of Wisconsin Investment Board
MRKR icon

State of Wisconsin Investment Board’s Marker Therapeutics MRKR Stock Holding History

State of Wisconsin Investment Board’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,070
Closed -$117K – 1716
2019
Q4 		$117K Hold
4,070
– – ﹤0.01% 1603
2019
Q3 		$208K Buy
+4,070
New +$241K ﹤0.01% 1500

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VWM
Vigilare Wealth Management Scottsdale, Arizona $326M AUM 21.58% 1-Year Est. Return

State of Wisconsin Investment Board's MRKR Position: Q1 2020 in Review

State of Wisconsin Investment Board sold out of Marker Therapeutics (MRKR) in Q1 2020, closing a stake of 4,070 shares — an estimated $117K sold.

State of Wisconsin Investment Board first reported a position in MRKR in Q3 2019 and held it in 2 quarters. The position peaked at $208K in Q3 2019. 65 funds tracked by Wall St. Rank hold MRKR as of Q1 2020.

  • State of Wisconsin Investment Board reported no remaining Marker Therapeutics position as of Q1 2020 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 4,070 Marker Therapeutics shares in Q1 2020, an estimated $117K.
  • State of Wisconsin Investment Board first reported a position in Marker Therapeutics in Q3 2019 and held it in 2 quarters.
  • State of Wisconsin Investment Board's Marker Therapeutics position peaked at $208K in Q3 2019.
  • 65 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2020.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2020, filed 6 May 2020.